REMEDENT, INC. ANNOUNCES EXCLUSIVE DISTRIBUTION AGREEMENT WITH LEADING OTC DISTRITUBOR ENCOMPASSING THE NETHERLANDSDistribution Agreement |
|
|
|
You are currently viewing: This Distribution Agreement involves
REMEDENT, INC.. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here. |
|
|
|
Search Distribution Agreement by:
REMEDENT, INC. ANNOUNCES EXCLUSIVE DISTRIBUTION AGREEMENT WITH LEADING OTC DISTRITUBOR ENCOMPASSING THE NETHERLANDS
DEURLE, Belgium—December 14, 2007 - Remedent, Inc. (OTCBB: REMI) today announced that it has signed an exclusive distribution agreement with a leading OTC distributor in the Netherlands. The terms call for this distributor to sell a private label kit similar to Reme)sense™, to treat sensitive teeth in the Netherlands and calls for an initial order and a minimum yearly performance. Remedent has agreed to deliver the product in packed form and ready for sale, while the distributor will be responsible to promote and advertise the product to the marketplace within the Netherlands. The agreement gives the distributor exclusive distribution rights to sell and distribute this product in the Netherlands using all its own distribution channels. First shipments are expected to commence during the first quarter of 2008.
The product will be for sensitive teeth, which is one of the most common complaints adults have about their teeth. The kit will contain six foam strips and on double tray, similar to the Reme)sense kit. Each package contains enough strips to provide relief for a total of three months, by applying an easy, once-a-month 10-minute application.
Mr. Robin List, CEO of Remedent, noted, “We are pleased to have reached this agreement with a leading OTC distributor in the Netherlands and announce another distribution agreement for our teeth sensitizing product. We believe our new partner has the proper relationships to create market acceptability for a new approach and solution to those adults who suffer from sensitive teeth. We continue to anticipate additional distribution agreements, especially in Europe, where we need to partner with distribution leaders in each country where pharmacies tend to be highly fragmented and






